KRISTIN CURCIO: Open Payments
NPI 1538195276 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$660 in 13 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $217 · 2025 $660
Food & beverage: $660
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $334 |
| Janssen Biotech, Inc. | 2 | $144 |
| Tempus AI, Inc | 2 | $42 |
| GlaxoSmithKline, LLC. | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Lilly USA, LLC | 1 | $21 |
| Gilead Sciences, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
Products named: OPDIVO, RYBREVANT, REBLOZYL, XT CDX, JEMPERLI, ICLUSIG, Trodelvy, IBRANCE.
Industry payments across NC — which companies pay providers there.
